Skip to main content

Table 5 Responder rates (%) according to weekly incontinence episodes by gender (ITT)

From: Skeletal muscle-derived cell implantation for the treatment of sphincter-related faecal incontinence

  Female (N = 34) Male (N = 5) All (N = 39)
V2 V3 V4 V2 V3 V4 V2 V3 V4
R(0–19) 16.2 10.8 10.8 13.9 8.3 11.1 15.4 10.3 10.3
R(20–49) 37.8 18.9 10.8 33.3 16.7 8.3 35.9 17.9 10.3
R(50–99) 40.5 59.5 64.9 47.2 63.9 66.7 43.6 59.0 64.1
R(100) 5.4 10.8 13.5 5.6 11.1 13.9 5.1 12.8 15.4
  1. ITT intention to treat, N number of values, V visit, V2, V3 and V4 1, 6 and 12 months post implantation, R(0–19), R(20–49),R(50–99) and R(100) percentage of patients with decrease in weekly incontinence episodes of 0–19%, 20–49%, 50–99% and 100%, respectively from baseline (V0) to post-implantation visits